166 related articles for article (PubMed ID: 21425402)
1. Concise review: neutral endopeptidase (CD10): a multifaceted environment actor in stem cells, physiological mechanisms, and cancer.
Maguer-Satta V; Besançon R; Bachelard-Cascales E
Stem Cells; 2011 Mar; 29(3):389-96. PubMed ID: 21425402
[TBL] [Abstract][Full Text] [Related]
2. HSP27 and HSP70 interact with CD10 in C4-2 prostate cancer cells.
Dall'Era MA; Oudes A; Martin DB; Liu AY
Prostate; 2007 May; 67(7):714-21. PubMed ID: 17342744
[TBL] [Abstract][Full Text] [Related]
3. Receptor-mediated down-regulation of neutral endopeptidase (NEP; EC 3.4.24.11; CD10) on immature B lymphocytes by dexamethasone.
Cupic B; Breljak D; Gabrilovac J
Int J Mol Med; 2005 Jun; 15(6):1023-31. PubMed ID: 15870909
[TBL] [Abstract][Full Text] [Related]
4. Human cytomegalovirus infection downregulates expression of the cellular aminopeptidases CD10 and CD13.
Phillips AJ; Tomasec P; Wang EC; Wilkinson GW; Borysiewicz LK
Virology; 1998 Oct; 250(2):350-8. PubMed ID: 9792845
[TBL] [Abstract][Full Text] [Related]
5. Phorbol ester-mediated regulation of CD10/neutral endopeptidase transcripts in acute lymphoblastic leukemias.
Ishimaru F; Potter NS; Shipp MA
Exp Hematol; 1996 Jan; 24(1):43-8. PubMed ID: 8536791
[TBL] [Abstract][Full Text] [Related]
6. CD10 is a key enzyme involved in the activation of tumor-activated peptide prodrug CPI-0004Na and novel analogues: implications for the design of novel peptide prodrugs for the therapy of CD10+ tumors.
Pan C; Cardarelli PM; Nieder MH; Pickford LB; Gangwar S; King DJ; Yarranton GT; Buckman D; Roscoe W; Zhou F; Salles A; Chen TH; Horgan K; Wang YH; Nguyen T; Bebbington CR
Cancer Res; 2003 Sep; 63(17):5526-31. PubMed ID: 14500390
[TBL] [Abstract][Full Text] [Related]
7. An outsider's perspective--ecotaxis revisited: an integrative review of cancer environment, iron and immune system cells.
de Sousa M
Integr Biol (Camb); 2011 Apr; 3(4):343-9. PubMed ID: 21180734
[TBL] [Abstract][Full Text] [Related]
8. [Membrane metalloendopeptidase (CD10/CALLA): distribution, physiologic and pathophysiologic functions and its inhibitors].
Stanović S; Boranić M
Lijec Vjesn; 1998 May; 120(5):131-7. PubMed ID: 9748792
[TBL] [Abstract][Full Text] [Related]
9. [The relevance of neprilysin for systemic homeostasis and its involvement in the pathological processes].
Kubiak-Wlekły A; Niemir ZI
Pol Merkur Lekarski; 2009 Jul; 27(157):51-4. PubMed ID: 19650431
[TBL] [Abstract][Full Text] [Related]
10. Expression of the common acute lymphoblastic leukemia antigen (CD10) in mesenchymal tumors.
Mechtersheimer G; Möller P
Am J Pathol; 1989 May; 134(5):961-5. PubMed ID: 2541615
[TBL] [Abstract][Full Text] [Related]
11. [Neprilysin--structure of the gene and protein product and the localization of expression].
Kubiak-Wlekły A; Niemir ZI
Pol Merkur Lekarski; 2009 Jul; 27(157):48-50. PubMed ID: 19650430
[TBL] [Abstract][Full Text] [Related]
12. Loss of CD10 (neutral endopeptidase) is a frequent and early event in human prostate cancer.
Freedland SJ; Seligson DB; Liu AY; Pantuck AJ; Paik SH; Horvath S; Wieder JA; Zisman A; Nguyen D; Tso CL; Palotie AV; Belldegrun AS
Prostate; 2003 Apr; 55(1):71-80. PubMed ID: 12640663
[TBL] [Abstract][Full Text] [Related]
13. CD10 enhances metastasis of colorectal cancer by abrogating the anti-tumoural effect of methionine-enkephalin in the liver.
Kuniyasu H; Luo Y; Fujii K; Sasahira T; Moriwaka Y; Tatsumoto N; Sasaki T; Yamashita Y; Ohmori H
Gut; 2010 Mar; 59(3):348-56. PubMed ID: 19828468
[TBL] [Abstract][Full Text] [Related]
14. CD10 immunohistochemical staining in urothelial neoplasms.
Murali R; Delprado W
Am J Clin Pathol; 2005 Sep; 124(3):371-9. PubMed ID: 16191505
[TBL] [Abstract][Full Text] [Related]
15. Cell specific expression of CD10/neutral endopeptidase 24.11 gene in human prostatic tissue and cells.
Song J; Aumüller G; Xiao F; Wilhelm B; Albrecht M
Prostate; 2004 Mar; 58(4):394-405. PubMed ID: 14968440
[TBL] [Abstract][Full Text] [Related]
16. Is there a role for mammary stem cells in inflammatory breast carcinoma?: a review of evidence from cell line, animal model, and human tissue sample experiments.
Van Laere S; Limame R; Van Marck EA; Vermeulen PB; Dirix LY
Cancer; 2010 Jun; 116(11 Suppl):2794-805. PubMed ID: 20503411
[TBL] [Abstract][Full Text] [Related]
17. Distinct subcellular expression patterns of neutral endopeptidase (CD10) in prostate cancer predict diverging clinical courses in surgically treated patients.
Fleischmann A; Schlomm T; Huland H; Köllermann J; Simon P; Mirlacher M; Salomon G; Chun FH; Steuber T; Simon R; Sauter G; Graefen M; Erbersdobler A
Clin Cancer Res; 2008 Dec; 14(23):7838-42. PubMed ID: 19047112
[TBL] [Abstract][Full Text] [Related]
18. Downregulation of enkephalin-mediated inflammatory responses by CD10/neutral endopeptidase 24.11.
Shipp MA; Stefano GB; D'Adamio L; Switzer SN; Howard FD; Sinisterra J; Scharrer B; Reinherz EL
Nature; 1990 Sep; 347(6291):394-6. PubMed ID: 1699130
[TBL] [Abstract][Full Text] [Related]
19. Expression of the CD10 antigen (neutral endopeptidase) by mesenchymal tumors of the skin.
Kanitakis J; Bourchany D; Claudy A
Anticancer Res; 2000; 20(5B):3539-44. PubMed ID: 11131659
[TBL] [Abstract][Full Text] [Related]
20. Reduced neutrophil CD10 expression in nonhuman primates and humans after in vivo challenge with E. coli or lipopolysaccharide.
Kaneko T; Stearns-Kurosawa DJ; Taylor F; Twigg M; Osaki K; Kinasewitz GT; Peer G; Kurosawa S
Shock; 2003 Aug; 20(2):130-7. PubMed ID: 12865656
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
